Your session is about to expire
← Back to Search
Cognitive Training for Alzheimer's Disease (ENACT Trial)
ENACT Trial Summary
This trial will explore the effects of two forms of cognitive training on older adults, including cognitive, psychosocial, and lifestyle measures, as well as biomarkers. The study will also examine how cognitive and psychosocial factors within daily life account for the transfer of cognitive training to everyday function.
ENACT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowENACT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ENACT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have played video games for more than 2 hours per week in the last 2 years.You are currently using a brain training program like Brain HQ or Lumosity.People who are 55 to 85 years old and live independently in the community.You do not have dementia or Alzheimer's disease, and you scored 5 or higher on a phone screening test for memory issues.
- Group 1: BUD1
- Group 2: BUD2
- Group 3: BUD1 + TDD1
- Group 4: CSA40
- Group 5: TDD1
- Group 6: BUD1 + TDD2
- Group 7: BUD1 + BUD2 + TDD2
- Group 8: CSA10
- Group 9: BUD1 + BUD2 + TDD1
- Group 10: BUD1 + TDD1 + TDD2
- Group 11: BUD1 + BUD2 + TDD1 + TDD2
- Group 12: BUD2 + TDD1
- Group 13: BUD2 + TDD1 + TDD2
- Group 14: CSA20
- Group 15: CSA30
- Group 16: TDD1 + TDD2
- Group 17: BUD2 + TDD2
- Group 18: No contact
- Group 19: BUD1 + BUD2
- Group 20: TDD2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the enrollment criteria for this clinical trial encompass individuals beyond 60 years of age?
"This clinical trial is admitting participants aged between 55 and 85 years old."
What qualifications must prospective participants have to enroll in this medical experiment?
"This clinical trial seeks 280 elderly individuals, aged 55 to 85 years old, who are currently diagnosed with Alzheimer's disease. Eligible participants must also demonstrate written comprehension and oral fluency in English; have obtained consent forms; scored 5 or higher on an MIS-t administered during phone screening; and be willing to provide two blood samples at baseline and posttest over the course of nine months."
What is the ceiling on patient participation for this investigative endeavor?
"Affirmative. According to clinicaltrials.gov, this study is currently accepting enrolment applications; its initial post date was February 21st 2022 and it was last updated on May 4th 2022. The medical trial requires 280 participants at a single research centre."
Are there any opportunities to enroll in this trial at present?
"The clinical data available on clinicialtrials.gov confirms that this research project is actively recruiting participants. It was first made public on February 21st 2022 and has since been updated as of May 4th 2022."
Share this study with friends
Copy Link
Messenger